LBF20107PG01: Difference between revisions
No edit summary |
No edit summary |
||
Line 14: | Line 14: | ||
|IR Spectra=METHYL ESTER ; <FONT FACE="Symbol">n</FONT> 1726, 1717sh, 1699, 980 cm<SUP><FONT SIZE=-1>-</FONT></SUP><SUP><FONT SIZE=-1>1</FONT></SUP> [[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]] | |IR Spectra=METHYL ESTER ; <FONT FACE="Symbol">n</FONT> 1726, 1717sh, 1699, 980 cm<SUP><FONT SIZE=-1>-</FONT></SUP><SUP><FONT SIZE=-1>1</FONT></SUP> [[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]] | ||
|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR(CDCl<SUB><FONT SIZE=-1>3</FONT></SUB>+DMSO-d<SUB><FONT SIZE=-1>6</FONT></SUB>,TMS) : <FONT FACE="Symbol">d</FONT> 5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H)[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]. <SUP><FONT SIZE=-1>1</FONT></SUP><SUP><FONT SIZE=-1>3</FONT></SUP>C-NMR(CHCl<SUB><FONT SIZE=-1>3</FONT></SUB>-CH<SUB><FONT SIZE=-1>3</FONT></SUB>OH, TMS) : <FONT FACE="Symbol">d</FONT> 215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) [[Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515|{{RelationTable/GetFirstAuthor|Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515}}]] | |NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR(CDCl<SUB><FONT SIZE=-1>3</FONT></SUB>+DMSO-d<SUB><FONT SIZE=-1>6</FONT></SUB>,TMS) : <FONT FACE="Symbol">d</FONT> 5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H)[[Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461|{{RelationTable/GetFirstAuthor|Reference:Hayashi_M:Miyamoto_T:,Metabolism and Disease (Taisha),1975,12,1461}}]]. <SUP><FONT SIZE=-1>1</FONT></SUP><SUP><FONT SIZE=-1>3</FONT></SUP>C-NMR(CHCl<SUB><FONT SIZE=-1>3</FONT></SUB>-CH<SUB><FONT SIZE=-1>3</FONT></SUB>OH, TMS) : <FONT FACE="Symbol">d</FONT> 215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) [[Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515|{{RelationTable/GetFirstAuthor|Reference:Lukacs_G:Piriou_F:Gero_SD:,Tetrah. Lett.,1973,,515}}]] | ||
|Source=Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml [[Reference:Bergstrom_S:,Science,1967,157,382|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:,Science,1967,157,382}}]] | |Source=Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml [[Reference:Bergstrom_S:,Science,1967,157,382|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:,Science,1967,157,382}}]], and has been found in ovine seminal plasma and seminal vesicle, human menstrual and amniotic flluid, human uterine endometrium, umbilical cord, placental vessels and decidua, frog spinal cord, rat adrenal, human and bovine thymus, frog intestine, rat fat tissue, and human phrenic nerve [[Reference:Horton_EW:,Physiol. Rev.,1969,49,122|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Physiol. Rev.,1969,49,122}}]][[Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111|{{RelationTable/GetFirstAuthor|Reference:Speroff_L:Ramwell_PW:,Am. J. Obstet. Gynecol.,1970,107,1111}}]][[Reference:Horton_EW:,Experientia,1965,21,113|{{RelationTable/GetFirstAuthor|Reference:Horton_EW:,Experientia,1965,21,113}}]][[Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Hillier_K:Devlin_J:,J. Pharm. Pharmacol.,1968,20,749}}]][[Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340|{{RelationTable/GetFirstAuthor|Reference:Karim_SM:Sandler_M:Williams_ED:,Br. J. Pharmacol. Chemother.,1967,31,340}}]][[Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165|{{RelationTable/GetFirstAuthor|Reference:Kirtland_SJ:,Prostaglandins Leukot. Essent. Fatty Acids,1988,32,165}}]]. | ||
|Chemical Synthesis=[[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]] | |Chemical Synthesis=[[Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535|{{RelationTable/GetFirstAuthor|Reference:Corey_EJ:Vlattas_I:Harding_K:,J. Am. Chem. Soc.,1969,91,535}}]] {{Image200|LBF20107PG01FT0001.gif}} | ||
|Metabolism=Prostagalndin E1 is produced from H1 at almost the same rate of E2 synthesis from H2 by an enzyme of bovine seminal vesicle [[Reference:Ogino_N:Miyamoto_T:Yamamoto_S:Hayaishi_O:,J. Biol. Chem.,1977,252,890|{{RelationTable/GetFirstAuthor|Reference:Ogino_N:Miyamoto_T:Yamamoto_S:Hayaishi_O:,J. Biol. Chem.,1977,252,890}}]] | |Metabolism=Prostagalndin E1 is produced from H1 at almost the same rate of E2 synthesis from H2 by an enzyme of bovine seminal vesicle [[Reference:Ogino_N:Miyamoto_T:Yamamoto_S:Hayaishi_O:,J. Biol. Chem.,1977,252,890|{{RelationTable/GetFirstAuthor|Reference:Ogino_N:Miyamoto_T:Yamamoto_S:Hayaishi_O:,J. Biol. Chem.,1977,252,890}}]]. | ||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Revision as of 11:55, 25 November 2009
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1400 |
LipidMaps | LMFA03010134 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20107PG01 |
PROSTAGLANDIN E1 | |
---|---|
Structural Information | |
7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -heptanoic acid / (8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid | |
| |
Formula | C20H34O5 |
Exact Mass | 354.240624198 |
Average Mass | 354.48096000000004 |
SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CCCCCCC(O)=O)[C@@H](CC1=O)O)CC |
Physicochemical Information | |
115-117°C | |
DIETHYL ETHER, ETHYL ACETATE , METHANOL Struijk_MCB et al., TETRAHYDROFURAN Corey_EJ et al. | |
Prostaglandin E1 is contained in human seminal plasma in an amount of 25 microgram/ml Bergstrom_S , and has been found in ovine seminal plasma and seminal vesicle, human menstrual and amniotic flluid, human uterine endometrium, umbilical cord, placental vessels and decidua, frog spinal cord, rat adrenal, human and bovine thymus, frog intestine, rat fat tissue, and human phrenic nerve Horton_EW Speroff_L et al. Horton_EW Karim_SM et al. Karim_SM et al. Kirtland_SJ . | |
Corey_EJ et al. | |
Prostagalndin E1 is produced from H1 at almost the same rate of E2 synthesis from H2 by an enzyme of bovine seminal vesicle Ogino_N et al.. | |
Spectral Information | |
Mass Spectra | METHYL ESTER ; m/e 350, 332, 319, 301, 279 HambergMet al. |
UV Spectra | |
IR Spectra | METHYL ESTER ; n 1726, 1717sh, 1699, 980 cm-1 HayashiMet al. |
NMR Spectra | 1H-NMR(CDCl3+DMSO-d6,TMS) : d 5.70-5.51(m, 2H), 4.14-3.86(m, 2H), 2.72(d,d, 1H) HayashiMet al.. 13C-NMR(CHCl3-CH3OH, TMS) : d 215.2(C-9), 176.7(C-1), 136.6(C-14), 131.9(C-13), 72.9(C-15), 71.6(C-11), 54.6(C-8), 54.2(C-12), 45.9(C-10), 36.9(C-16), 33.8(C-2), 31.5(C-18), 29.0(C-4), 28.6(C-5), 27.4(C-7), 26.3(C-6), 25.0(C-17), 24.5(C-3), 22.5(C-19), 13.8(C-20) LukacsGet al. |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|